AmfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million

Gladstone in the News | By | October 16, 2025 | 1 min read

Up Next

Portrait of Michael Alexanian in front of Gladstone Institutes

Article August 25, 2026

Ask a Scientist: Can We Turn Off the Molecular Switches That Cause Heart Failure?

Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.

Alexanian Lab Cardiovascular Disease Human Genetics Grants Congenital Heart Disease

Nadia Roan and Melanie Ott in conversation at Gladstone Institutes

Article July 17, 2026

Gladstone Scientists Are Awarded $2 Million to Map How HIV Affects the Immune System

By uniting the power of single-cell sequencing, organoids, and artificial intelligence, scientists are entering a new era of HIV research.

Roan Lab Ott Lab Grants HIV/AIDS Organoids AI

Gladstone scientists leading the Center for PhAIge Therapy

Article June 2, 2026

Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections

The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.

News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AI

AmfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million

Ask a Scientist: Can We Turn Off the Molecular Switches That Cause Heart Failure?

Gladstone Scientists Are Awarded $2 Million to Map How HIV Affects the Immune System

Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!